Recent publications

UDIBI

SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library SHOW MORE

UDIBI

Isolation and characterization of high affinity and highly stable anti-Chikungunya virus antibodies using ALTHEA Gold Libraries™. SHOW MORE

UDIBI

An international comparative analysis and roadmap to sustainable biosimilar markets. SHOW MORE

UDIBI

Efficacy, Pharmacokinetics, and Toxicity Profiles of Broad Anti-SARS-CoV-2 Neutralizing Antibody. SHOW MORE

UDIBI

SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library SHOW MORE

UDIBI

Colloids and Surfaces A: Physicochemical and Engineering Aspects. Structural and physicochemical characteristics of one-step PAMAM dendrimeric nanoparticles. SHOW MORE

UDIBI

Quality attributes of partially hydrolyzed collagen in a liquid formulation used for skin care. SHOW MORE

UDIBI

Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract “Transferon Oral”: The Starting Point to Understand Its Mechanism of Action. SHOW MORE

UDIBI

Characterization of a Complex Mixture of Immunomodulator Peptides Obtained from Autologous Urine. SHOW MORE

UDIBI

Taking advantage of a high-throughput flow cytometer for the implementation of an ADCC assay for regulatory compliance. SHOW MORE

UDIBI

Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile. IN PRESS SHOW MORE

UDIBI

Transferon in 2020 SHOW MORE

UDIBI

Validation of a cell proliferation assay to assess the potency of a Dialyzable Leucocyte Extract intended for batch release. SHOW MORE

UDIBI

Identity Profiling of Complex Mixtures of Peptide Products by Structural and Mass Mobility Orthogonal Analysis. SHOW MORE

UDIBI

Phage Display Libraries for Antibody Therapeutic Discovery and Development. SHOW MORE

UDIBI

Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®). SHOW MORE

UDIBI

Validation of a cell-based colorimetric reporter gene assay for the evaluation of Type I Interferons. SHOW MORE

UDIBI

CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with LPS and Dialyzable Leukocyte Extract (Transferon®). SHOW MORE

UDIBI

Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality Attributes. SHOW MORE

UDIBI

Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc región. SHOW MORE

UDIBI

The yin/yang of inflammatory status: Blood-brain barrier regulation during sleep. SHOW MORE

UDIBI

Mycobacterium tuberculosis Catalase Inhibits the Formation of Mast Cell Extracellular Traps. SHOW MORE

UDIBI

ALTHEA Gold Libraries™: antibody libraries for therapeutic antibody discovery. SHOW MORE

UDIBI

Published: april 10, 2019 CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with LPS and Dialyzable Leukocyte Extract (Transferon®) More information

UDIBI

Published: September, 2019 A differential sex-specific pattern of IgG2 and IgG4 subclasses of anti-drug antibodies (ADAs) induced by glatiramer acetate in relapsing-remitting multiple sclerosis patients More information

UDIBI

Published: may 16, 2019 Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract Transferon®) More information

UDIBI

Published: September 20, 2019 Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable Leukocyte Extract Intended for Batch Release. More information

UDIBI

Published: September 20, 2019 Utilization of naproxen by Amycolatopsis sp. Poz 14 and detectionof the enzymes involved in the degradation metabolic pathway. More information

UDIBI

Fecha de publicación: Enero 2019Valproic acid promotes a decrease in mycobacterial survival by enhancing nitric oxide production in macrophages stimulated with IFN-γ.More information

UDIBI

Published: april 2nd, 2020 Development and Evaluation of a Set of Spike and Receptor Binding Domain‐Based Enzyme‐Linked Immunosorbent Assays for SARS‐CoV‐2 Serological Testing More information

UDIBI

Published: march 20, 2021 Consistency of a dialyzable leucocyte extract manufactured at GMPfacilities by Nuclear magnetic resonance spectroscopy More information

UDIBI

Published : March 2021 Poor survival in COVID-19 associated with Lymphopenia and Higher Neutrophile-Lymphocyte ratio More information

UDIBI

October 6, 2021 Increased survival in puppies affected by Canine Parvovirus type II using an immunomodulator as a therapeutic aid More information

UDIBI

Published: August 28, 2022 Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies More information

UDIBI

Published: September 6, 2022 In Vitro and In Vivo Characterization of a Broadly Neutralizing Anti-SARS-CoV-2 Antibody Isolated from a Semi-ImmunePhage Display Library More information

UDIBI

November 8, 22 Altered neutrophil-to-lymphocyte ratio in sepsis secondary to canine parvoviral enteritis treated with and without an immunomodulator in puppies More information

UDIBI

Published: February 27, 2023 Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus Libraries™ More information

UDIBI

Isolation and characterization of high affinity and highly stable anti-Chikungunya virus antibodies using ALTHEA Gold Libraries™. SHOW MORE

UDIBI

An international comparative analysis and roadmap to sustainable biosimilar markets. SHOW MORE

UDIBI

Efficacy, Pharmacokinetics, and Toxicity Profiles of Broad Anti-SARS-CoV-2 Neutralizing Antibody. SHOW MORE

©2024 UDIBI Powered by Starlight Studio

Select your currency
× How can I help you?

Log in with your credentials

Forgot your details?